health
Maintaining momentum and morale during the long road to FDA approval, with Robhy Bustami, BioticsAI
Surviving the long road to FDA approval isn’t just about building great technology — it’s about keeping your team motivated, finding the right investors, and learning how to operate when timelines are uncertain. This week on Build Mode, Isabelle Johannessen sits down with Robhy Bustami, co-founder and CEO of BioticsAI, a Startup Battlefield-winning company building [...]
TL;DR
- Keeping a team motivated and aligned during the uncertain FDA approval process.
- Navigating the FDA process from the initial stages of startup development.
- Securing investors who comprehend the high-risk, slow-burn nature of medtech.
- The importance of cross-functional collaboration involving engineers, clinicians, and researchers.
- The value of active industry experts over renowned but disengaged advisors.
- Building and sustaining momentum and celebrating achievements amidst long timelines.